Skip to main content
Filing year 2024

Translational Research Cancer Cente

Pittsburgh, Pennsylvania·EIN 83-1794049·NTEE G30 · Diseases, Disorders & Medical Disciplines·501(c)(3)
Total revenue
$240k
Total assets
$214k
Total expenses
$122k
Reported officers
27
Mission

Dissemination of information regarding the prevention, treatment, and cure of cancer, integrating cancer biology and tumor immunology. Promoting research, clinical collaborations, enhanced partnerships with industry, and training of the next generation of scientists.

Reported officers (all unpaid)

No paid executives reported in 2024. Translational Research Cancer Cente reported 27 unpaid officers and board members on its 990.

Director
Director
Director
Director
Director
Director
Director
Director
Director
Meeting Co-organizer
Meeting Co-organizer
Director
Director
Director
Director
Director
Director
Director
Director
Director
Director
Past President
President
Past President
Secretary
Vice President
Treasurer
Financial trend

Revenue and expenses over time

Translational Research Cancer Cente reported revenue and expenses across 2 filing years.

RevenueExpenses
$115k
$124k
2023
$240k
$122k
2024
Total revenue and total expenses from IRS Form 990 filings.
Sector benchmark

What Diseases, Disorders & Medical Disciplines executives earn in Pennsylvania

Translational Research Cancer Cente reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable diseases, disorders & medical disciplines organization in Pennsylvania earns a median of $100,168.

25th percentile
$50k
Median
$100,168
75th percentile
$156k
90th percentile
$320k

These are diseases, disorders & medical disciplines sector-wide figures, not this organization's reported pay. Based on 130 organizations across 130 filings (2022 – 2024).

See full Diseases, Disorders & Medical Disciplines pay data for Pennsylvania
FAQ

Common questions about Translational Research Cancer Cente

What are Translational Research Cancer Cente's revenue and expenses?

In 2024, Translational Research Cancer Cente reported $240k in total revenue and $122k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.